Dr. Vibhor Sharma is at the forefront of CAR-T Cell Therapy, an innovative immunotherapy for treating certain blood cancers. CAR-T therapy harnesses the body’s immune system to target and destroy cancer cells effectively. Dr. Sharma’s expertise ensures that patients receive precise, safe, and cutting-edge treatment. This therapy is particularly beneficial for relapsed or refractory leukemia and lymphoma that do not respond to conventional treatments. With advanced facilities and rigorous patient care protocols, Dr. Sharma offers one of the most advanced therapeutic options available in Hematology-Oncology today.

What is CAR-T Cell Therapy:
CAR-T Cell Therapy (Chimeric Antigen Receptor T-cell Therapy) involves modifying a patient’s own T-cells to recognise and attack cancer cells. These engineered cells are then infused back into the patient to destroy malignant cells effectively.

Procedure:

1. T-cell collection from the patient’s blood.
2. Genetic modification of T-cells in a lab to produce chimeric antigen receptors (CARs).
3. Expansion of modified T-cells to sufficient numbers.
4. Infusion of CAR-T cells back into the patient.
5. Monitoring for side effects like cytokine release syndrome and managing them promptly.

Treatment:
CAR-T therapy is followed by close monitoring, supportive care, and regular follow-ups to assess response and long-term efficacy. Dr. Vibhor Sharma ensures that every patient receives individualized care and guidance throughout the treatment journey.